Minneapolis, May 6, 2016 -- Cinnamon may lessen the risk of cardiovascular damage of a high-fat diet by activating the body's antioxidant and anti-inflammatory systems and slowing the fat-storing process, according to a preliminary animal study presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology | Peripheral Vascular Disease 2017 Scientific Sessions.
In the study, researchers fed rats cinnamon supplements for 12 weeks along with a high-fat diet. They found:
- The rats weighed less and had less belly fat and healthier levels of sugar, insulin and fat in their blood, compared to rats that did not receive cinnamon with their high-fat foods;
- Rats fed cinnamon also had fewer molecules involved in the body's fat-storing process and more antioxidant and anti-inflammatory molecules that protect the body from the damages of stress.
The results suggest that cinnamon may reduce the effects of a high-fat diet, researchers said.
###
Vijaya Juturu, Ph.D., OmniActive Health Technologies Inc, Morristown, NJ.
Additional Resources:
- Photos available on the right column of the release link http://newsroom.heart.org/news/cinnamon-may-lessen-damage-of-high-fat-diet-in-rats?preview=8832aa437c34afa3942dda3235df3761
- The American Heart Association's Diet and Lifestyle Recommendations
- The Skinny on Fats
- Follow AHA/ASA news on Twitter @HeartNews #ATVBPVD17
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at http://www.heart.org/corporatefunding.